Pharmacoepidemiology and Drug Safety 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.---
Pharmacoepidemiology and Drug Safety, Ahead of Print. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 13, 2018 Category: Drugs & Pharmacology Source Type: research
Importance of the lipid ‐related pathways in the association between statins, mortality, and cardiovascular disease risk: The Multi‐Ethnic Study of Atherosclerosis
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Source Type: research
Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Source Type: research
Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 253-262, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety, Ahead of Print. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 253-262, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Source Type: research
Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey
ConclusionsA large majority of patients who were dispensed varenicline recalled receiving the MG and were able to correctly recall neuropsychiatric and cardiovascular risks in all 3 surveys. The varenicline MG may be an effective tool for patient education. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Authors: Kandace L. Amend, Muhammad Younus, Kenneth R. Petronis, Jingping Mo, John D. Seeger, Robert Gately, Xiangmei Gu, Cheryl Enger Tags: ORIGINAL REPORT Source Type: research
Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study
ConclusionAlgorithms that rely exclusively on primary discharge code position will miss approximately 50% of all MI cases due to low sensitivity of this definition. We recommend defining MI by code 410 in any of first 5 discharge code positions overall and by codes 410 and 411.1 in any of first 3 positions for sensitivity analyses of women. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 6, 2018 Category: Drugs & Pharmacology Authors: Montika Bush, Til St ürmer, Sally C. Stearns, Ross J. Simpson, M. Alan Brookhart, Wayne Rosamond, Anna M. Kucharska‐Newton Tags: ORIGINAL REPORT Source Type: research
Issue Information
No abstract is available for this article. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 4, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research
Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation
(Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 4, 2018 Category: Drugs & Pharmacology Authors: Jasper H.A. Miert, Karina Meijer Tags: LETTER TO THE EDITOR Source Type: research
Issue Information
No abstract is available for this article. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 4, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 332-339, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 2, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 332-339, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 2, 2018 Category: Drugs & Pharmacology Source Type: research
Sequential surveillance for drug safety in a regulatory environment
(Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - February 1, 2018 Category: Drugs & Pharmacology Authors: David Martin, Joshua J. Gagne, Susan Gruber, Rima Izem, Jennifer C. Nelson, Michael D. Nguyen, Rita Ouellet ‐Hellstrom, Sebastian Schneeweiss, Sengwee Toh, Alexander M. Walker Tags: COMMENTARY Source Type: research
